摘要
目的研究头孢匹罗治疗社区获得性肺炎(CAP)的临床疗效和安全性。方法 60例CAP患者随机分为试验组和对照组,试验组给予头孢匹罗治疗,对照组给予头孢地嗪治疗,疗程7～14d。结果试验组、对照组临床有效率分别为93.3%和70%,细菌清除率分别为92%和65.2%,两组治疗不良反应均轻微,安全性好。结论头孢匹罗治疗社区获得性肺炎疗效显著,细菌清除率高,优于头孢地嗪。
Objective To evaluate the clinical efficacy and safety of Cefipirome in the treatment of community-acquired pneumonia （ CAP ） . Methods 60 patients with CAP were randomly divided into two groups, injective Cefipirome was given in the observed group, cefodizime in the controlled group.The course of treatment was 7 - 14d.Resu Its The clinical effective rate of Cefipirome group was 93.3%; the bacterial clearance rate was 88%. While that of cefodizime group was 60% and 65%.The adverse effects are mild and welltolerated.Conc I us i on Cefipirome is more effective and with high capability of bacteria eradication than cefodizime in treating CAP.
出处
《首都医药》
2012年第20期39-41,共3页
Capital Medicine
